ArticleUrolithiasis2026
Association between gastroesophageal reflux disease and kidney stone disease in cross-sectional and longitudinal analyses.
Article in Urolithiasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastroesophageal reflux disease (GERD) has been linked to multiple systemic conditions, but its association with kidney stone disease (KSD) has not been well established. This study examined whether GERD is associated with an increased risk of KSD in a large Taiwanese population. A cross-sectional study was conducted in 121,550 Taiwan Biobank participants, including 16,657 individuals with self-reported GERD. Multivariable logistic regression models were used to assess the association between GERD and prevalent KSD. In addition, a prospective longitudinal cohort of 27,024 participants without KSD at baseline was followed for an average of 47 months to evaluate incident KSD using Cox proportional hazards models. In the cross-sectional analysis, the prevalence of kidney stones was higher among participants with GERD (9%) compared with those without GERD (6%). GERD was associated with prevalent KSD after multivariable adjustment (adjusted odds ratio, 1.57; 95% CI, 1.48–1.67). In the longitudinal cohort, GERD was also associated with an increased risk of incident KSD during follow-up (adjusted hazard ratio, 1.54; 95% CI, 1.22–1.93). GERD was associated with both prevalent and incident KSD in this population. These findings highlight the potential importance of recognizing and managing GERD to reduce KSD risk.
Indexed as
Identifiers
41984233What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.